ADAM-17：全酶。
ADAM-17: the enzyme that does it all.
机构信息
Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.
出版信息
Crit Rev Biochem Mol Biol. 2010 Apr;45(2):146-69. doi: 10.3109/10409231003628015.
Abstract
This review focuses on the role of ADAM-17 in disease. Since its debut as the tumor necrosis factor converting enzyme (TACE), ADAM-17 has been reported to be an indispensible regulator of almost every cellular event from proliferation to migration. The central role of ADAM-17 in cell regulation is rooted in its diverse array of substrates: cytokines, growth factors, and their receptors as well as adhesion molecules are activated or inactivated by their cleavage with ADAM-17. It is therefore not surprising that ADAM-17 is implicated in numerous human diseases including cancer, heart disease, diabetes, rheumatoid arthritis, kidney fibrosis, Alzheimer's disease, and is a promising target for future treatments. The specific role of ADAM-17 in the pathophysiology of these diseases is very complex and depends on the cellular context. To exploit the therapeutic potential of ADAM-17, it is important to understand how its activity is regulated and how specific organs and cells can be targeted to inactivate or activate the enzyme.
摘要
本篇综述聚焦于 ADAM-17 在疾病中的作用。自其作为肿瘤坏死因子转化酶（TACE）首次被报道以来，ADAM-17 已被证实是几乎所有细胞事件（从增殖到迁移）的不可或缺的调节剂。ADAM-17 在细胞调控中的核心作用源于其多样化的底物：细胞因子、生长因子及其受体以及黏附分子通过 ADAM-17 的切割而被激活或失活。因此，ADAM-17 与多种人类疾病（包括癌症、心脏病、糖尿病、类风湿性关节炎、肾纤维化、阿尔茨海默病）有关，这并不奇怪，它是未来治疗的有希望的靶点。ADAM-17 在这些疾病的病理生理学中的具体作用非常复杂，并且取决于细胞环境。为了开发 ADAM-17 的治疗潜力，了解其活性如何被调节以及如何靶向特定的器官和细胞以失活或激活该酶非常重要。
相似文献
1
ADAM-17: the enzyme that does it all.ADAM-17：全酶。
Crit Rev Biochem Mol Biol. 2010 Apr;45(2):146-69. doi: 10.3109/10409231003628015.
2
ADAM17, shedding, TACE as therapeutic targets.ADAM17、脱落、TACE 作为治疗靶点。
Pharmacol Res. 2013 May;71:19-22. doi: 10.1016/j.phrs.2013.01.012. Epub 2013 Feb 13.
3
ADAM17 as a therapeutic target in multiple diseases.ADAM17作为多种疾病的治疗靶点。
Curr Pharm Des. 2009;15(20):2319-35. doi: 10.2174/138161209788682398.
4
Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.使用糖基化和非糖基化底物发现新型解整合素金属蛋白酶 17（ADAM17）抑制剂。
J Biol Chem. 2012 Oct 19;287(43):36473-87. doi: 10.1074/jbc.M112.389114. Epub 2012 Aug 27.
5
Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1).肿瘤坏死因子-α转化酶（TACE/ADAM-17）介导细胞间黏附分子-1（ICAM-1）的胞外域裂解。
J Biol Chem. 2006 Feb 10;281(6):3157-64. doi: 10.1074/jbc.M510797200. Epub 2005 Dec 6.
6
The evaluation of inhibitive effectiveness of the tumour necrosis factor-α converting enzyme selective inhibitors by HPLC.高效液相色谱法评价肿瘤坏死因子-α转化酶选择性抑制剂的抑制效果。
J Enzyme Inhib Med Chem. 2011 Apr;26(2):181-7. doi: 10.3109/14756366.2010.487485.
7
[The two sides of ADAM17 in inflammation: implications in atherosclerosis and obesity].[ADAM17在炎症中的两面性：对动脉粥样硬化和肥胖症的影响]
Med Sci (Paris). 2009 Jan;25(1):45-50. doi: 10.1051/medsci/200925145.
8
Tumor necrosis factor-alpha converting enzyme: Implications for ocular inflammatory diseases.肿瘤坏死因子-α转化酶：眼部炎症性疾病的影响。
Int J Biochem Cell Biol. 2010 Jul;42(7):1076-9. doi: 10.1016/j.biocel.2010.03.011. Epub 2010 Mar 18.
9
Role of ADAMs in cancer formation and progression.ADAMs在癌症形成和进展中的作用。
Clin Cancer Res. 2009 Feb 15;15(4):1140-4. doi: 10.1158/1078-0432.CCR-08-1585.
10
Therapeutic potential of TACE inhibitors in stroke.TACE抑制剂在中风治疗中的潜力。
Curr Drug Targets CNS Neurol Disord. 2005 Apr;4(2):161-8. doi: 10.2174/1568007053544147.
引用本文的文献
1
Role of Tumor Necrosis Factor in Tuberculosis.肿瘤坏死因子在结核病中的作用。
Biomolecules. 2025 May 12;15(5):709. doi: 10.3390/biom15050709.
2
A genome-scale drug discovery pipeline uncovers new therapeutic targets and a unique p97 allosteric binding site in .一个全基因组规模的药物发现流程揭示了新的治疗靶点以及……中一个独特的p97变构结合位点。
bioRxiv. 2025 Mar 15:2025.03.14.643303. doi: 10.1101/2025.03.14.643303.
3
Organic Dust Exposure Enhances SARS-CoV-2 Entry in a PKC- and ADAM-17-Dependent Manner.有机粉尘暴露以依赖蛋白激酶C和金属蛋白酶17的方式增强严重急性呼吸综合征冠状病毒2的进入。
Int J Transl Med (Basel). 2024;4(3):486-497. doi: 10.3390/ijtm4030032.
4
Analysis of Biomarker Levels in Nasopharyngeal Swabs, Serum, and Saliva Across Different Health Conditions.不同健康状况下鼻咽拭子、血清和唾液中生物标志物水平的分析。
Life (Basel). 2025 Feb 19;15(2):324. doi: 10.3390/life15020324.
5
Acute hyperglycemia induces podocyte apoptosis by monocyte TNF-α release, a process attenuated by vitamin D and GLP-1 receptor agonists.急性高血糖通过单核细胞释放肿瘤坏死因子-α（TNF-α）诱导足细胞凋亡，这一过程可被维生素D和胰高血糖素样肽-1（GLP-1）受体激动剂所减弱。
J Steroid Biochem Mol Biol. 2025 Mar;247:106676. doi: 10.1016/j.jsbmb.2025.106676. Epub 2025 Jan 14.
6
Updates on Inflammatory Molecular Pathways Mediated by ADAM17 in Autoimmunity.ADAM17介导的自身免疫炎症分子途径的研究进展
Cells. 2024 Dec 18;13(24):2092. doi: 10.3390/cells13242092.
7
Sleep drive is coupled to tissue damage via shedding of Caenorhabditis elegans EGFR ligand SISS-1.睡眠驱动力通过秀丽隐杆线虫表皮生长因子受体（EGFR）配体SISS-1的脱落与组织损伤相关联。
Nat Commun. 2024 Dec 30;15(1):10886. doi: 10.1038/s41467-024-55252-4.
8
Repurposing raltegravir for reducing inflammation and treating cancer: a bioinformatics analysis.将雷特格韦重新用于减轻炎症和治疗癌症：一项生物信息学分析。
Sci Rep. 2024 Dec 5;14(1):30349. doi: 10.1038/s41598-024-82065-8.
9
Inhibiting ADAM17 enhances the efficacy of olaparib in ovarian cancer spheroids.抑制 ADAM17 可增强奥拉帕利在卵巢癌细胞球中的疗效。
Sci Rep. 2024 Nov 6;14(1):26926. doi: 10.1038/s41598-024-78442-y.
10
Inhibition of ADAM17 attenuates high glucose-induced angiogenesis and inflammation in endothelial cells partly through down-regulation of GRO-α/CXCR2 expression: implications in peritoneal dialysis.抑制ADAM17可部分通过下调GRO-α/CXCR2表达减轻高糖诱导的内皮细胞血管生成和炎症：对腹膜透析的意义
Clin Exp Nephrol. 2024 Dec;28(12):1232-1240. doi: 10.1007/s10157-024-02546-y. Epub 2024 Sep 21.
本文引用的文献
1
TNFalpha shedding and epidermal inflammation are controlled by Jun proteins.肿瘤坏死因子α的释放和表皮炎症受Jun蛋白调控。
Genes Dev. 2009 Nov 15;23(22):2663-74. doi: 10.1101/gad.543109.
2
Timp-3 deficiency impairs cognitive function in mice.组织金属蛋白酶抑制因子3（Timp-3）缺乏会损害小鼠的认知功能。
Lab Invest. 2009 Dec;89(12):1340-7. doi: 10.1038/labinvest.2009.101. Epub 2009 Oct 5.
3
Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.通过对 4 种肺癌细胞系条件培养基的蛋白质组学分析鉴定 5 个候选肺癌生物标志物。
Mol Cell Proteomics. 2009 Dec;8(12):2746-58. doi: 10.1074/mcp.M900134-MCP200. Epub 2009 Sep 23.
4
Klotho is a substrate for alpha-, beta- and gamma-secretase.klotho是α-、β-和γ-分泌酶的底物。
FEBS Lett. 2009 Oct 6;583(19):3221-4. doi: 10.1016/j.febslet.2009.09.009. Epub 2009 Sep 6.
5
Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10.金属蛋白酶TACE和ADAM10识别底物的活性位点决定因素。
Biochem J. 2009 Oct 23;424(1):79-88. doi: 10.1042/BJ20090549.
6
ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices.ADAM17 与 TIMP-3 共纯化，并调节三维胶原基质中的内皮细胞侵袭反应。
Matrix Biol. 2009 Oct;28(8):470-9. doi: 10.1016/j.matbio.2009.07.007. Epub 2009 Aug 8.
7
Activation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice.内皮细胞固有核因子κB途径的激活损害蛋白C抗凝机制并促进内毒素血症小鼠的凝血。
Blood. 2009 Sep 17;114(12):2521-9. doi: 10.1182/blood-2009-02-205914. Epub 2009 Jul 20.
8
Tumor necrosis factor-alpha-converting enzyme is a key regulator of agonist-induced cardiac hypertrophy and fibrosis.肿瘤坏死因子-α转化酶是激动剂诱导的心脏肥大和纤维化的关键调节因子。
Hypertension. 2009 Sep;54(3):575-82. doi: 10.1161/HYPERTENSIONAHA.108.127670. Epub 2009 Jul 6.
9
Up-regulation of soluble Axl and Mer receptor tyrosine kinases negatively correlates with Gas6 in established multiple sclerosis lesions.在已形成的多发性硬化症病灶中，可溶性Axl和Mer受体酪氨酸激酶的上调与生长停滞特异性蛋白6呈负相关。
Am J Pathol. 2009 Jul;175(1):283-93. doi: 10.2353/ajpath.2009.080807. Epub 2009 Jun 18.
10
CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.CB - 12181是一种新型的基于氮杂糖的基质金属蛋白酶/肿瘤坏死因子-α转换酶抑制剂，在体外可抑制血管内皮生长因子诱导的血管生成，在体内可抑制视网膜新生血管形成。
Curr Neurovasc Res. 2009 Aug;6(3):140-7. doi: 10.2174/156720209788970072. Epub 2009 Aug 1.
Zotero 插件